2026-10-13T02:13:40Z https://data.mendeley.com/oai

oai:data.mendeley.com/pvc6pmwx9z.1 2026-06-30T04:28:59Z

Smith, Purvi Irvine_Growth and bone biomarkers_Supplementary material_JAAD 2026 Mendeley Data Supplementary material to the article titled "Dupilumab treatment improves linear growth and bone biomarkers in children with atopic dermatitis: Post hoc analysis of a phase 3 randomized, placebo-controlled clinical trial and an open-label extension study" Contents: Page Plain Language Summary 2 Laboratory measurements 4 Supplementary Figure 1. Atopic dermatitis. Mean BALP over time to week 52 in patients with and without asthma comorbidity. 5 Supplementary Figure 2. Atopic dermatitis. A, Osteocalcin (OC); B, procollagen type 1 N-terminal propeptide (P1NP); C, insulin-like growth factor 1 (IGF-1); D, C-terminal crosslinking telopeptide of type-1 collagen (CTX-1) over time to week 52. 6 Pediatrics Biologic Therapy Atopic Dermatitis Bone Growth Irvine, Alan Paller, Amy Siegfried, Elaine Cork, Michael Beck, Lisa Eichenfield, Lawrence Swanson, Lisa Hamon, Sara Horowitz, Julie Farrell, Annamaria Hatsell, Sarah Zhang, Annie Bansal, Ashish You, Xiaojun Chen, Zhen Levy, Stephane Cyr, Sonya Dataset doi:10.17632/pvc6pmwx9z.1 oai:data.mendeley.com/pvc6pmwx9z.1 Creative Commons Attribution 4.0 International http://creativecommons.org/licenses/by/4.0 https://data.mendeley.com/datasets/pvc6pmwx9z 2026-06-30T04:28:59Z